Assessment of the risk factors of coronary heart events based on data mining with decision trees
AuthorKaraolis, Minas A.
Moutiris, Joseph Antoniou
Pattichis, Constantinos S.
SourceIEEE Transactions on Information Technology in Biomedicine
Google Scholar check
MetadataShow full item record
Coronary heart disease (CHD) is one of the major causes of disability in adults as well as one of the main causes of death in the developed countries. Although significant progress has been made in the diagnosis and treatment of CHD, further investigation is still needed. The objective of this study was to develop a data-mining system for the assessment of heart event-related risk factors targeting in the reduction of CHD events. The risk factors investigated were: 1) before the event: a) nonmodifiable-age, sex, and family history for premature CHD, b) modifiable-smoking before the event, history of hypertension, and history of diabetesand 2) after the event: modifiable-smoking after the event, systolic blood pressure, diastolic blood pressure, total cholesterol, highdensity lipoprotein, low-density lipoprotein, triglycerides, and glucose. The events investigated were: myocardial infarction (MI), percutaneous coronary intervention (PCI), and coronary artery bypass graft surgery (CABG). A total of 528 cases were collected from the Paphos district in Cyprus, most of them with more than one event. Data-mining analysis was carried out using the C4.5 decision tree algorithm for the aforementioned three events using five different splitting criteria. The most important risk factors, as extracted from the classification rules analysis were: 1) for MI, age, smoking, and history of hypertension2) for PCI, family history, history of hypertension, and history of diabetesand 3) for CABG, age, history of hypertension, and smoking. Most of these risk factors were also extracted by other investigators. The highest percentages of correct classifications achieved were 66%, 75%, and 75% for the MI, PCI, and CABG models, respectively. It is anticipated that data mining could help in the identification of high and low risk subgroups of subjects, a decisive factor for the selection of therapy, i.e., medical or surgical. However, further investigation with larger datasets is still needed. © 2006 IEEE.
Showing items related by title, author, creator and subject.
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis Athyros, Vasilios G.; Tziomalos, Konstantinos; Gossios, Thomas D.; Griva, Theodora; Anagnostis, Panagiotis; Kargiotis, Konstantinos; Pagourelias, Efstathios D.; Theocharidou, Eleni; Karagiannis, Asterios; Mikhailidis, Dimitri P.; Basdekas, S.; Bouloukos, V.; Christaki, Eirini; Dimopoulou, S.; Hartamba, E.; Kakafika, A.; Kapousouzi, M.; Koumaras, H.; Mitsiou, E.; Papageorgiou, A.; Pehlivanidis, A.; Petridis, D.; Sekeri, Z.; Skaperdas, A.; Symeonidis, A. (2010)Long-term statin treatment reduces the frequency of cardiovascular events, but safety and efficacy in patients with abnormal liver tests is unclear. We assessed whether statin therapy is safe and effective for these patients ...
Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population Vasilakou, M.; Votteas, V.; Kasparian, C.; Pantazopoulos, N.; Dedoussis, George V. Z.; Constantinou-Deltas, Constantinos D.; Nastos, P.; Nikolakis, D.; Lamnissou, Klea (2008)Objective - Genetic polymorphisms in the gene for endothelial nitric oxide synthase have been considered as potential risk factors for the development of coronary artery disease in some populations. Methods - We studied ...
Georgoulias, Panagiotis; Valotassiou, Varvara; Wozniak, Greta; Demakopoulos, Nikolaos; Fezoulidis, Ioannis (2008)Coronary revascularization procedures (coronary artery bypass graft - CABG surgery, percutaneous coronary intervention - PCI) are widely used in patients with coronary artery disease (CAD). By assessing myocardial perfusion, ...